272. Do Empiric Antibiotics Improve Outcomes in Clinically Stable Patients Admitted with COVID-19 Pneumonia? Retrospective Cohort Study of 221 U.S. Hospitals, March 1st, 2020-December 31st, 2020

BACKGROUND: Patients admitted with COVID19 pneumonia often receive initial empiric antibacterial therapy (IEAT) despite a known low probability of bacterial co-infection. However, evidence supporting this practice is lacking. We studied the impact of IEAT on the risk of in-hospital mortality, clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawandi, Alexander, Strich, Jeffrey R, Li, Xioabai, Yek, Christina, Warner, Sarah, Kadri, Sameer S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751610/
http://dx.doi.org/10.1093/ofid/ofac492.350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751610/
http://dx.doi.org/10.1093/ofid/ofac492.350

Ejemplares similares